Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Our research focuses on the relationship between metabolism, hypoxia and the diabetic heart.  We have investigated the mechanisms the heart employs to adapt to a decrease in oxygen availability, regulating changes within mitochondrial oxidative and anaerobic glycolytic metabolism. We have shown that metabolic adaptation to hypoxia is abnormal in the type 2 diabetic heart, and have identified some of the mechanisms involved.  We are employing various pharmacological strategies to correct these processes, both directly via metabolic modulators, and indirectly via activation of hypoxic signalling pathways.  These strategies may provide an approach to improve ischemic recovery in the diabetic heart.

If you have a question about this talk, please contact Sarah Noujaim.

DPAG Head of Department Seminar Series